SOLICITATION NOTICE
A -- Research - Investigation of inequivalence of bupropion hydrochloride extended release tablets: in vitro metabolism quantification - RFQ-FDA-1120924
- Notice Date
- 7/29/2013
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- RFQ-FDA-1120924
- Archive Date
- 8/27/2013
- Point of Contact
- Lacetta T. Bowman, Phone: 3018276790
- E-Mail Address
-
Lacetta.Bowman@fda.hhs.gov
(Lacetta.Bowman@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- Research - Investigation of inequivalence of bupropion hydrochloride extended release tablets: in vitro metabolism quantification
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/RFQ-FDA-1120924/listing.html)
- Record
- SN03130068-W 20130731/130729234616-be5b4755e79ea9a065926d2aec3e7607 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |